Wavelength expands API supply for respiratory drugs in US and Europe

API supplier Wavelength Pharmaceuticals has also announced availability of its new CDMO services

picture of

Breaking News

CordenPharma extends lipid excipients agreement with Moderna

The agreement has enabled CordenPharma to manufacture large-scale volumes of Moderna's lipid excipients to be used in ...

WuXi launches closed-process CAR-T cell therapy platform

CDMO WuXi Advanced Therapies has announced the expansion of its service capabilities to offer a fully integrated closed ...

Vibalogics to support Johnson & Johnson vaccine effort

The global CDMO that specialises in the production of virotherapy products has announced that it will manufacture ...

Zenith on the buzzwords for pharma 2020

Joe Haugh, Zenith Technologies CEO, describes 2019 as a real watershed year, with topics such as Industry 4.0, ...

Quotient and CytoAgents accelerate treatment for COVID-19 cytokine storm

Collaboration expedites human clinical trials for COVID-19 drug candidate

Merck invests $109m in viral vector and gene therapy manufacturing

German Merck has announced a second Carlsbad, California facility to double its BioReliance viral and gene therapy ...

Delivering certainty in uncertain times

Contract manufacturing organisations (CMOs) in the pharmaceutical sector operate at the sharp end of an industry in ...

Wavelength expands API supply for respiratory drugs in US and Europe

API supplier Wavelength Pharmaceuticals has also announced availability of its new CDMO services

Ritedose selects ChargePoint Technology’s transfer solution for biomanufacturing project

The AseptiSafe Bio Transfer Valve uses an enhanced decontamination step to provide a validated 6-log reduction in ...

Integrated solutions offer fast-track development for biopharmaceuticals

At the heart of any successful medicine launch is a robust manufacturing process that will reliably make the product in ...

John Baker: life sciences need to address the reproducibility crisis

The head of product innovation at Abcam says it is crucial that the whole industry finds ways to de-risk the route to ...

Lonza reveals process development roadmap for cell and gene therapies

Behnam Baghbaderani of Lonza Pharma & Biotech examines four manufacturing challenges inherent to the production of ...

FDA approves Xellia US facility for CMO injectables

The increased capacity will be used to grow and scale Xellia’s own pipeline as well as widening its offering of CMO ...

High-throughput technologies: a paradigm shift in biopharmaceutical development

The growing demand for innovative biopharmaceutical products is putting pressure on the pharmaceutical biotechnology ...